Yamaha Motor Co., Ltd. (Tokyo: 7272) announced today the upcoming release of the new CELL HANDLER(TM) 2, a cell picking and imaging system set to launch in March 2025. This advanced system aims to ...
Initial Clinical Data from Phase 1 Autoimmunity Study of FT819 1XX CAR T-cell Product Candidate to be Presented in 4Q24; Second Treatment Arm ...
A Phase I study of invikafusp alfa presented at SITC provided the rationale to enroll patients with TMB-high, MSI-high, and virus-associated tumors in Phase II.
The TOC (Translocon at the Outer envelope of Chloroplasts)-TIC (Translocon at the Inner envelope of Chloroplasts) ...
Immune cells are capable of detecting infections just like a sniffer dog, using special sensors known as Toll-like receptors, ...
Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...
Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and Malignant ...
The Brighterside of News on MSN7d
Space-cultured stem cells show potential to cure cancer and heart diseaseStem cells grown in microgravity aboard the International Space Station (ISS) are showing potential to transform treatments ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data across ...
About Fate Therapeutics, Inc. Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a ...
RoslinCT is pleased to announce the appointment of Jessica Carmen, Ph.D., to its global leadership team as Chief Commercial ...
A new human skin atlas and skin organoid could revolutionize treatments for skin disorders and enhance regenerative medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback